The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Complete Immunosuppression Withdrawal and Subsequent Allograft Function Among Pediatric Recipients of Parental Living Donor Liver Transplants
Abstract
CONTEXT: Although life-saving, liver transplantation burdens children with lifelong immunosuppression and substantial potential for morbidity and mortality. OBJECTIVE: To establish the feasibility of immunosuppression withdrawal in pediatric living donor liver transplant recipients. DESIGN, SETTING, AND PATIENTS: Prospective, multicenter, open-label, single-group pilot trial conducted in 20 stable pediatric recipients (11 male; 55%) of parental living donor liver transplants for diseases other than viral hepatitis or an autoimmune disease who underwent immunosuppression withdrawal. Their median age was 6.9 months (interquartile range [IQR], 5.5-9.1 months) at transplant and 8 years 6 months (IQR, 6 years 5 months to 10 years 9 months) at study enrollment. Additional entry requirements included stable allograft function while taking a single immunosuppressive drug and no evidence of acute or chronic rejection or significant fibrosis on liver biopsy. Gradual immunosuppression withdrawal over a minimum of 36 weeks was instituted at 1 of 3 transplant centers between June 5, 2006, and November 18, 2009. Recipients were followed up for a median of 32.9 months (IQR, 1.0-49.9 months). MAIN OUTCOME MEASURES: The primary end point was the proportion of operationally tolerant patients, defined as patients who remained off immunosuppression therapy for at least 1 year with normal graft function. Secondary clinical end points included the durability of operational tolerance, and the incidence, timing, severity, and reversibility of rejection. RESULTS: Of 20 pediatric patients, 12 (60%; 95% CI, 36.1%-80.9%) met the primary end point, maintaining normal allograft function for a median of 35.7 months (IQR, 28.1-39.7 months) after discontinuing immunosuppression therapy. Follow-up biopsies obtained more than 2 years after completing withdrawal showed no significant change compared with baseline biopsies. Eight patients did not meet the primary end point secondary to an exclusion criteria violation (n = 1), acute rejection (n = 2), or indeterminate rejection (n = 5). Seven patients were treated with increased or reinitiation of immunosuppression therapy; all returned to baseline allograft function. Patients with operational tolerance compared with patients without operational tolerance initiated immunosuppression withdrawal later after transplantation (median of 100.6 months [IQR, 71.8-123.5] vs 73.0 months [IQR, 57.6-74.9], respectively; P = .03), had less portal inflammation (91.7% [95% CI, 61.5%-99.8%] vs 42.9% [95% CI, 9.9%-81.6%] with no inflammation; P = .04), and had lower total C4d scores on the screening liver biopsy (median of 6.1 [IQR, 5.1-9.3] vs 12.5 [IQR, 9.3-16.8]; P = .03). CONCLUSION: In this pilot study, 60% of pediatric recipients of parental living donor liver transplants remained off immunosuppression therapy for at least 1 year with normal graft function and stable allograft histology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Skin cancers after organ transplantation
Euvrard, S., Kanitakis, J., & Claudy, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022137 · Cited by 1,575
Banff Schema for Grading Liver Allograft Rejection: An International Consensus Document
Demetris, A. J., Batts, K. P., Dhillon, A. P., Ferrell, L., Fung, J., Geller, S. A., Hart, J., Hayry, P., Hofmann, W. J., Hubscher, S., et al. (1997) · Hepatology · doi:10.1002/hep.510250328 · Cited by 1,272
Self-citationCell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
Starzl, T. E., Demetris, A. J., Trucco, M., Murase, N., Ricordi, C., Ildstad, S., Ramos, H., Todo, S., Tzakis, A., Fung, J. J., et al. (1993) · Hepatology · doi:10.1002/hep.1840170629 · Cited by 810
Self-citationWEANING OF IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS12
Mazariegos, G. V., Reyes, J., Marino, I. R., Demetris, A. J., Flynn, B., Irish, W., McMichael, J., Fung, J. J., & Starzl, T. E. (1997) · Transplantation · doi:10.1097/00007890-199701270-00012 · Cited by 411
Self-citationMultiparameter Immune Profiling of Operational Tolerance in Liver Transplantation
Martínez-Llordella, M., Puig-Pey, I., Orlando, G., Ramoni, M., Tisone, G., Rimola, A., Lerut, J., Latinne, D., Margarit, C., Bilbao, I., et al. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01621.x · Cited by 374
WEANING OF IMMUNOSUPPRESSION IN LIVING DONOR LIVER TRANSPLANT RECIPIENTS1
Takatsuki, M., Uemoto, S., Inomata, Y., Egawa, H., Kiuchi, T., Fujita, S., Hayashi, M., Kanematsu, T., & Tanaka, K. (2001) · Transplantation · doi:10.1097/00007890-200108150-00016 · Cited by 296
Weaning Of Immunosuppression In Long-Term Liver Transplant Recipients
Ramos, H. C., Reyes, J., Abu-Elmagd, K., Zeevi, A., Reinsmoen, N., Tzakis, A., Demetris, A. J., Fung, J. J., Flynn, B., McMichael, J., et al. (1995) · Transplantation · doi:10.1097/00007890-199501270-00010 · Cited by 238
Self-citationDefining the outcome of immunosuppression withdrawal after liver transplantation
Devlin, J., Doherty, D., Thomson, L., Wong, T., Donaldson, P., Portmann, B., & Williams, R. (1998) · Hepatology · doi:10.1002/hep.510270406 · Cited by 238
Psychological Functioning, Nonadherence and Health Outcomes After Pediatric Liver Transplantation
Fredericks, E. M., Lopez, M. J., Magee, J. C., Shieck, V., & Opipari‐Arrigan, L. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01878.x · Cited by 195
Koshiba, T., Li, Y., Takemura, M., Wu, Y., Sakaguchi, S., Minato, N., Wood, K. J., Haga, H., Ueda, M., & Uemoto, S. (2007) · Transplant Immunology · doi:10.1016/j.trim.2006.10.004 · Cited by 186
Tisone, G., Orlando, G., Cardillo, A., Palmieri, G., Manzia, T. M., Baiocchi, L., Lionetti, R., Anselmo, A., Toti, L., & Angelico, M. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.047 · Cited by 163
THE FLOW CYTOMETRIC CROSSMATCH
Bray, R. A., Lebeck, L. K., & Gebel, H. M. (1989) · Transplantation · doi:10.1097/00007890-198911000-00022 · Cited by 124
Tryphonopoulos, P., Tzakis, A. G., Weppler, D., Garcia-Morales, R. O., Kato, T., Madariaga, J. R., Levi, D., Nishida, S., Moon, J., Selvaggi, G., et al. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00743.x · Cited by 117
Tolerance: Is It Worth the Risk?
Eason, J. D., Cohen, A. J., Nair, S. P., Alcantera, T., & Loss, G. E. (2005) · Transplantation · doi:10.1097/01.tp.0000162084.46555.10 · Cited by 105
Pons, J. A., Yélamos, J., Ramı́rez, P., Oliver‐Bonet, M., Sánchez, A., Rodríguez-Gago, M., Navarro, J., Bermejo, J., Robles-Campos, R., & Parrilla, P. (2003) · Transplantation · doi:10.1097/01.tp.0000058472.71775.7d · Cited by 101
Isse, K., Lesniak, A. J., Grama, K., Roysam, B., Minervini, M., & Demetris, A. J. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03797.x · Cited by 89
Self-citationSandborn, W. J., Hay, E. J., Porayko, M. K., Gores, G. J., Steers, J. L., Krom, R. A. F., & Wiesner, R. H. (1994) · Hepatology · doi:10.1002/hep.1840190419 · Cited by 87
Regulatory T Cells in Transplantation: Transferring Mouse Studies to the Clinic
Long, E., & Wood, K. J. (2009) · Transplantation · doi:10.1097/tp.0b013e3181bb7913 · Cited by 74
Assy, N., Adams, P. C., Myers, P., Simon, V., Minuk, G. Y., Wall, W. J., & Ghent, C. N. (2007) · Transplantation · doi:10.1097/01.tp.0000266678.32250.76 · Cited by 66
Bellamy, C. O. C., Herriot, M. M., Harrison, D. J., & Bathgate, A. J. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02677.x · Cited by 64
Tolerance and latent cellular rejection in long-term liver transplant recipients
Wong, T., Nouri‐Aria, K. T., Devlin, J., Portmann, B. C., & Williams, R. L. (1998) · Hepatology · doi:10.1002/hep.510280223 · Cited by 63
Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective
Demetris, A. J., Lunz, J. G., Randhawa, P. S., Wu, T., Nalesnik, M. A., & Thomson, A. W. (2008) · Transplant International · doi:10.1111/j.1432-2277.2008.00765.x · Cited by 60
Self-citationTwenty‐four‐hour ambulatory blood pressure profiles in liver transplant recipients
Compare, M. E. D., D’Agostino, D., Ferraris, J. R., Boldrini, G., Waisman, G. D., & Krmar, R. T. (2004) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2004.00192.x · Cited by 28
Cited by
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082
Demetris, A. J., Bellamy, C., Hübscher, S. G., O’Leary, J., Randhawa, P. S., Feng, S., Neil, D., Colvin, R. B., McCaughan, G., Fung, J. J., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13909 · Cited by 650
Self-citationTodo, S., Yamashita, K., Goto, R., Zaitsu, M., Nagatsu, A., Oura, T., Watanabe, M., Aoyagi, T., Suzuki, T., Shimamura, T., et al. (2016) · Hepatology · doi:10.1002/hep.28459 · Cited by 441
Self-citationBenítez, C., Londoño, M.-C., Miquel, R., Manzia, T.-M., Abraldes, J. G., Lozano, J.-J., Martínez-Llordella, M., López, M., Angelico, R., Bohne, F., et al. (2013) · Hepatology · doi:10.1002/hep.26426 · Cited by 318
Liver Transplantation 2023: Status Report, Current and Future Challenges
Terrault, N. A., Francoz, C., Berenguer, M., Charlton, M., & Heimbach, J. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.04.005 · Cited by 314
Metadata
- Authors
- Feng, S., Ekong, U. D., Lobritto, S. J., Demetris, A. J., Roberts, J. P., Rosenthal, P., Alonso, E. M., Philogene, M. C., Ikle, D., Poole, K. M., Bridges, N. D., Turka, L. A., & Tchao, N. K.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2012-01-18
- Volume
- 307
- Issue
- 3
- Pages
- 283-93
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2117600377
- Cited by
- 359
- References
- 24
- FWCI
- 37.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.